Payden & Rygel Investment Group Eli Lilly & CO Transaction History
Payden & Rygel Investment Group
- $1.24 Billion
- Q2 2024
A detailed history of Payden & Rygel Investment Group transactions in Eli Lilly & CO stock. As of the latest transaction made, Payden & Rygel Investment Group holds 24,220 shares of LLY stock, worth $17.6 Million. This represents 1.77% of its overall portfolio holdings.
Number of Shares
24,220
Previous 26,520
8.67%
Holding current value
$17.6 Million
Previous $20.6 Million
6.29%
% of portfolio
1.77%
Previous 0.97%
Shares
6 transactions
Others Institutions Holding LLY
# of Institutions
4,002Shares Held
752MCall Options Held
8.27MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$70.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$53.6 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$47.9 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$37.3 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$24.6 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $691B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...